Pain Management for Patients on Suboxone and Nortriptyline

Introduction to Pain Management Options

The National Comprehensive Cancer Network recommends nortriptyline as a first-line treatment for neuropathic pain 1
Gabapentin and pregabalin are effective additional pain management options for patients with neuropathic pain components, particularly when combined with nortriptyline 1

The National Comprehensive Cancer Network suggests starting gabapentin at 100-300 mg nightly and increasing to 900-3600 mg daily in divided doses, with dose adjustments for renal insufficiency 1
Pregabalin can be started at 50 mg three times daily, increased to 100 mg three times daily, with a maximum dose of 600 mg in divided doses, and also requires dose adjustment for renal insufficiency 1

The combination of nortriptyline and gabapentin has been shown to be superior to either medication alone for neuropathic pain, according to the Mayo Clinic Proceedings 2
Anticonvulsants provide complementary pain relief through different mechanisms than opioids and tricyclic antidepressants 3

The National Comprehensive Cancer Network recommends considering topical agents such as lidocaine patch 5% or topical NSAIDs like diclofenac gel or patch for additional pain relief 1

The Mayo Clinic Proceedings advises caution when combining tramadol with nortriptyline due to the potential risk of serotonin syndrome 4
The National Comprehensive Cancer Network suggests monitoring for increased sedation when adding anticonvulsants to the existing regimen 5
The Mayo Clinic Proceedings recommends avoiding medications that may cause QT-interval prolongation when combined with buprenorphine 4

The National Comprehensive Cancer Network recommends monitoring for side effects, assessing pain control using standardized pain scales, and evaluating potential drug-drug interactions at each medication change 1, 4, 6
Consider referral to a pain specialist for interventional approaches if pharmacological management is inadequate, as suggested by the National Comprehensive Cancer Network 5

The American Academy of Neurology recommends combining pregabalin with either extended-release opioids (morphine or oxycodone) or nortriptyline for nerve impingement pain, as both combinations have demonstrated superior pain relief compared to pregabalin alone in randomized controlled trials 7

The combination of pregabalin and extended-release oxycodone or morphine provides better pain relief at lower doses of each medication compared to either agent alone, according to the Mayo Clinic Proceedings 7
Gabapentin (similar mechanism to pregabalin) combined with extended-release morphine required lower dosages of both medications while achieving superior pain control in patients with neuropathic pain, as reported in the Mayo Clinic Proceedings 7
An open-label study of 403 neuropathic pain patients showed that pregabalin plus extended-release oxycodone improved pain relief at lower individual doses, enhanced quality of life, and demonstrated better tolerability than monotherapy, as found in the Mayo Clinic Proceedings 7
A low-dose oxycodone trial (10 mg/day) combined with pregabalin showed no additional benefit versus placebo, indicating that adequate opioid dosing is essential for combination efficacy, according to the Mayo Clinic Proceedings 7

The strongest evidence supports pregabalin combined with extended-release opioids or nortriptyline, both demonstrating superiority over monotherapy in randomized controlled trials, as reported in the Mayo Clinic Proceedings 7